Immunotherapy of Mild Cognitive Impairment by ω-3 Supplementation: Why Are Amyloid-β Antibodies and ω-3 Not Working in Clinical Trials? Fiala M, Restrepo L, Pellegrini M J Alzheimers Dis. 2018; 62(3):1013-1022. PMID: 29103035. Abstract Comment Bookmark Recommend Follow Comment | Bookmark | Recommend | Follow